No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs45537140 |
chr19:42212613-42212614 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs190377739 |
chr19:42212621-42212622 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs45614132 |
chr19:42212622-42212623 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs115233397 |
chr19:42212644-42212645 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionCpG islandChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs267605502 |
chr19:42212661-42212662 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs201518445 |
chr19:42212664-42212665 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs200391100 |
chr19:42212689-42212690 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs200859918 |
chr19:42212701-42212702 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive regionlncRNA
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs538013635 |
chr19:42212739-42212740 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs144340352 |
chr19:42212744-42212745 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs200207181 |
chr19:42212745-42212746 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs111973464 |
chr19:42212753-42212754 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs72455487 |
chr19:42212754-42212755 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs3217253 |
chr19:42212755-42212756 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs114263190 |
chr19:42212797-42212798 |
Weak transcription Active TSS Enhancers Bivalent/Poised TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs544755548 |
chr19:42212811-42212812 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
TF binding regionChromatin interactive region
|
3 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs8113098 |
chr19:42212819-42212820 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs182639723 |
chr19:42212826-42212827 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs542655390 |
chr19:42212874-42212875 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
TF binding region
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs562323116 |
chr19:42212908-42212909 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs187608648 |
chr19:42212919-42212920 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs544761106 |
chr19:42212941-42212942 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs76806056 |
chr19:42212974-42212975 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs369318726 |
chr19:42212981-42212982 |
Weak transcription Active TSS Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs533603769 |
chr19:42213000-42213001 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs551460723 |
chr19:42213014-42213015 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs529125196 |
chr19:42213027-42213028 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs73545178 |
chr19:42213029-42213030 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs547621122 |
chr19:42213030-42213031 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs527630512 |
chr19:42213066-42213067 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
CpG island
|
2 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs548985087 |
chr19:42213104-42213105 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs567514133 |
chr19:42213112-42213113 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs565830362 |
chr19:42213122-42213123 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs539766150 |
chr19:42213128-42213129 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs112637399 |
chr19:42213137-42213138 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs537734302 |
chr19:42213162-42213163 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs556449609 |
chr19:42213192-42213193 |
Weak transcription Active TSS Bivalent Enhancer Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs117222609 |
chr19:42213223-42213224 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs569702888 |
chr19:42213240-42213241 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs538875906 |
chr19:42213243-42213244 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs553862876 |
chr19:42213252-42213253 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs572175711 |
chr19:42213261-42213262 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs4802127 |
chr19:42213276-42213277 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs554620558 |
chr19:42213277-42213278 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs555480936 |
chr19:42213291-42213292 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs111736472 |
chr19:42213295-42213296 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs375743111 |
chr19:42213359-42213360 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs544559768 |
chr19:42213360-42213361 |
Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs147741773 |
chr19:42213407-42213408 |
Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs59654817 |
chr19:42213408-42213409 |
Weak transcription Active TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|